ESTABLISHED
JUNE 1978
HEAD QUARTER
SEOUL, KOREA
EMPLOYEES
ABOUT 620
CEO & President | Wonbum Lee |
---|---|
Sales Revenue(2022) | 194,258Million KRW |
Stock Exchange Index | KOSPI |
Head Office | Seoul, Korea |
KGMP Plant | Anseong, Korea |
R&D center | Suwon, Korea / Seoul, Korea |
Main Therapeutic Areas | Central Nervous System (80%) Cardiovascular (6%) Gastrointestinal (3%) |
Main Products | Quetiapine/Alprazolam/Agomelatine/Donepezil |